Aptamer-engineered extracellular vesicles enable targeted celecoxib delivery for in vitro breast and colon cancer therapy
Scientific Reports - Aptamer-engineered extracellular vesicles enable targeted celecoxib delivery for in vitro breast and colon cancer therapy